-
AI, Machine Learning & Computational Biology7 months agoWhite House misses deadline to nominate new CDC director
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. So you know how Theresa said yesterday that...
-
AI, Machine Learning & Computational Biology7 months agoSTAT+: Data show people racing to chatbots for health advice
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your...
-
AI, Machine Learning & Computational Biology7 months ago
Pulmatrix picked for reverse merger with anti-aging biotech weeks after Cullgen deal collapses
Pulmatrix may have been discarded by Cullgen, but the inhaled therapy biotech’s Nasdaq listing has caught the attention of another company.Read More
-
AI, Machine Learning & Computational Biology7 months ago
OrbiMed-backed Pinnacle adds $89M series B to power oral peptide pipeline
Oral peptide specialist Pinnacle Medicines has secured an $89 million series B with backing from investors in the U.S. and China, bringing the company’s total fundraising...
-
AI, Machine Learning & Computational Biology7 months ago
Wave crashes after obesity trial tracks 1% dip in body weight over 6 months
Wave Life Sciences linked its obesity drug candidate to a 1% dip in body weight after six months, leading investors to drive the stock down more...
-
AI, Machine Learning & Computational Biology7 months agoSTAT+: FDA approves Denali Therapeutics drug for Hunter syndrome
The Food and Drug Administration on Wednesday approved a new medicine from Denali Therapeutics for a condition called Hunter syndrome, a notable decision by the agency...
-
AI, Machine Learning & Computational Biology7 months agoSTAT+: A 2023 health AI bet that seems to be paying off
You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in...
-
AI, Machine Learning & Computational Biology7 months agoSTAT+: Sarepta Therapeutics shares rise on early promise for rare disease drugs
Sarepta Therapeutics’ next crop of medicines for muscular dystrophy appear to be safe and effective in early clinical trials, the company said, a positive though incremental...
-
AI, Machine Learning & Computational Biology7 months ago
Merck, girding for Keytruda cliff, flies toward promising CML asset with $6.7B Terns acquisition
Merck and Terns Pharmaceuticals have agreed to a $6.7 billion all-cash buyout that delivers a prized leukemia asset to the New Jersey Big Pharma.Read More
-
AI, Machine Learning & Computational Biology7 months agoOpinion: We’re launching a new CMS pilot program to help children with complex conditions
Our public health programs are failing the children who need them most. Together, Medicaid and the Children’s Health Insurance Program (CHIP) cover half of all children...
LncRNA SBF2-AS1 Worsens Heart Injury After Attack via miR-149-5p/PHLPP2 Axis
Stigmatizing language found in over half of primary care patient records
Research report: The Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Iclepertin (BI 425809): Results from Two Phase I Open-Label, Non-randomised, Single Dose, Parallel Design Studies
Novartis buys Synnovation’s PI3Kα inhibitors for $3 billion
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
